Costunolide-induced apoptosis is caused by receptor-mediated pathway and inhibition of telomerase activity in NALM-6 cells

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 5, 2008, Pages 1024-1028

  Kanno, Syu Ichi ^a   Kitajima, Yasue ^a   Kakuta, Mai ^a   Osanai, Yuu ^a   Kurauchi, Kaori ^a   Ujibe, Mayuko ^a   Ishikawa, Masaaki ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Caspase; Costunolide; NALM 6; Telomerase

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; COSTUNOLIDE; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS ASSOCIATED FACTOR 1 PROTEIN; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN DERIVATIVE; SERINE; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CELL DAMAGE; CELL NUCLEUS; CHRONOPHARMACOLOGY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; NUCLEOTIDE SEQUENCE; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CASPASES; CELL DIFFERENTIATION; CELL LINE, TUMOR; ENZYME INHIBITORS; HUMANS; RECEPTORS, DRUG; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SESQUITERPENES; SIGNAL TRANSDUCTION; TELOMERASE;

EID: 44349171180     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.1024     Document Type: Article

References (33)

1. Park H. J., Jung W. T., Basnet P., Kadota S., Namba T., J. Nat. Prod., 59, 1128-1130 (1996).
2. Chen H. C., Chou C. K., Lee S. D., Wang J. C., Yeh S. F., Antiviral. Res., 27, 99-109 (1995).
3. Wedge D. E., Galindo J. C., Macias F. A., Phytochemistry, 53, 747-757 (2000).
4. Mori H., Kawamori T., Tanaka T., Ohnishi M., Yamahara J., Cancer Lett., 83, 171-175 (1994).
5. Park S. H., Choi S. U., Lee C. O., Yoo S. E., Yoon S. K., Kim Y. K., Ryu S. Y., Planta Med., 67, 358-359 (2001).
6. Lee M. G., Lee K. T., Chi S. G., Park J. H., Biol. Pharm. Bull., 24, 303-306 (2001).
7. Park H. J., Kwon S. H., Han Y. N., Choi J. W., Miyamoto K., Lee S. H., Lee K. T., Arch. Pharm. Res., 24, 342-348 (2001).
8. Choi J. H., Ha J., Park J. H., Lee J. Y., Lee Y. S., Park H. J., Choi J. W., Masuda Y., Nakaya K., Lee K. T., Jpn. J. Cancer Res., 93, 1327-1333 (2002).
9. Hibasami H., Yamada Y., Moteki H., Katsuzaki H., Imai K., Yoshioka K., Komiya T., Int. J. Mol. Med., 12, 147-151 (2003).
10. Komiya T., Yamada Y., Moteki H., Katsuzaki H., Imai K., Hibasami H., Oncol. Rep., 11, 85-88 (2004).
11. Konopleva M., Zhao S., Xie Z., Segall H., Younes A., Claxton D. F., Estrov Z., Kornblau S. M., Andreeff M., Adv. Exp. Med. Biol., 457, 217-236 (1999).
12. Srivastava R. K., Neoplasia, 3, 535-546 (2001).
13. Counter C. M., Avilion A. A., LeFeuvre C. E., Stewart N. G., Greider C. W., Harley C. B., Bacchetti S., EMBO J., 11, 1921-1929 (1992).
14. Kim N. W., Piatyszek M. A., Prowse K. R., Harley C. B., West M. D., Ho P. L., Coviello G. M., Wright W. E., Weinrich S. L., Shay J. W., Science, 266, 2011-2015 (1994).
15. Shay J. W., Wright W. E., Curr. Opin. Oncol., 8, 66-71 (1996).
16. Colangelo D., Osella D., Curr. Med. Chem., 12, 3091-3102 (2005).
17. Choi S. H., Im E., Kang H. K., Lee J. H., Kwak H. S., Bae Y. T., Park H. J., Kim N. D., Cancer Lett., 227, 153-162 (2005).
18. Schiffer C. A., Semin. Hematol., 38, 22-26 (2001).
19. Kanno S., Matsukawa E., Miura A., Shouji A., Asou K., Ishikawa M., Biol. Pharm. Bull., 26, 964-968 (2003).
20. Mosmann T., J. Immunol. Methods, 65, 55-63 (1983).
21. Kanno S., Tomizawa A., Ohtake T., Koiwai K., Ujibe M., Ishikawa M., Toxicol. Lett., 166, 131-139 (2006).
22. Ponte P., Ng S. Y., Engel J., Gunning P., Kedes L., Nucleic Acids Res., 12, 1687-1696 (1984).
23. Chu K., Niu X., Williams L. T., Proc. Natl. Acad. Sci. U.S.A., 92, 11894-11898 (1995).
24. Boldin M. P., Varfolomeev E. E., Pancer Z., Mett I. L., Camonis J. H., Wallach D., J. Biol. Chem., 270, 7795-7798 (1995).
25. Scaffidi C., Volkland J., Blomberg I., Hoffmann I., Krammer P. H., Peter M. E., J. Immunol., 164, 1236-1242 (2000).
26. Werner M. H., Wu C., Walsh C. M., Cell Cycle, 5, 2332-2338 (2006).
27. Baker S. J., Reddy E. P., Oncogene, 17, 3261-3270 (1998).
28. Kitajima Y., Kanno S., Ujibe M., Uwai K., Takeshita M., Ishikawa M., "Abstract of Papers, 126th Annual Meeting of the Japanese Pharmaceutical Society," 2006, p. 85.
29. Tewari M., Quan L. T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D. R., Poirier G. G., Salvesen G. S., Dixit V. M., Cell, 81, 801-809 (1995).
30. Hahn W. C., Meyerson M., Ann. Med., 33, 123-129 (2001).
31. Pleschke J. M., Kleczkowska H. E., Strohm M., Althaus F. R., J. Biol. Chem., 275, 40974-40980 (2000).
32. Haendeler J., Hoffmann J., Rahman S., Zeiher A. M., Dimmeler S., FEBS Lett., 536, 180-186 (2003).
33. Cheng Y. L., Chang W. L., Lee S. C., Liu Y. G., Lin H. C., Chen C. J., Yen C. Y., Yu D. S., Lin S. Z., Harn H. J., Life Sci., 73, 2383-2394 (2003).